Homing of negatively charged albumins to the lymphatic system: General implications for drug targeting to peripheral tissues and viral reservoirs

The present study shows the lymphatic distribution of the negatively charged anti-HIV-1 agents succinylated or aconytilated human serum albumins (HSAs) in rats. Quantitation of blood and lymphatic concentrations of these proteins was performed through fluorescence detection of the fluorescein isothi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical pharmacology 1999-11, Vol.58 (9), p.1425-1435
Hauptverfasser: Swart, Pieter J, Beljaars, Leonie, Kuipers, Mirjam E, Smit, Catharina, Nieuwenhuis, Paul, Meijer, Dirk K.F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1435
container_issue 9
container_start_page 1425
container_title Biochemical pharmacology
container_volume 58
creator Swart, Pieter J
Beljaars, Leonie
Kuipers, Mirjam E
Smit, Catharina
Nieuwenhuis, Paul
Meijer, Dirk K.F
description The present study shows the lymphatic distribution of the negatively charged anti-HIV-1 agents succinylated or aconytilated human serum albumins (HSAs) in rats. Quantitation of blood and lymphatic concentrations of these proteins was performed through fluorescence detection of the fluorescein isothiocyanate (FITC)-labeled proteins. At several time points after i.v. injection, samples were taken from the cannulated thoracic duct and the carotid artery. Distribution of the negatively charged albumins (NCAs) to lymph was much more rapid than that of albumin itself and was dependent on the total net negative charge added to the protein: the half-life times of lymphatic equilibration were 15, 30, and 120 min for FITC-labeled aconytilated HSA, FITC-labeled succinylated HSA, and FITC-labeled HSA, respectively. Lymph to blood concentration ratios of the studied compounds obtained at steady state approached unity. In addition, the fluorescence in both body fluids was shown to represent unchanged labeled proteins. It was therefore inferred that the NCAs efficiently passed the endothelial barrier from blood to the interstitial compartment. Subsequently, we studied whether a specialized process was involved in the endothelial passage of the NCAs to the lymph. The following observations supported such a mechanism: a) preinjection of the scavenger receptor blockers polyinosinic- and formaldehyde-treated HSA reduced the transport from blood to the lymphatic compartment of FITC-labeled aconytilated HSA by more than 90%; b) the rate of lymphatic distribution was largely reduced when the body temperature of the rat was lowered to 28°; and c) pre-administration of chloroquine resulted in a significant reduction in the lymphatic distribution of the NCAs. These data collectively indicate that a scavenger receptor-mediated process is involved in the transendothelial transport of NCAs. In situ localization in lymph nodes of the rat showed that FITC-labeled aconytilated and succinylated HSA are mainly present in the germinal center and parafollicular zones. The efficient distribution of these anionized proteins to the lymphatic system is of particular interest for HIV therapy, taking into account that replication of HIV mainly takes place in the lymphoid system. The observation that macromolecules, through charge modification, can extravasate through a receptor-mediated transcytotic process is potentially of major importance for the delivery of drugs with macromolecular carriers
doi_str_mv 10.1016/S0006-2952(99)00224-5
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70824440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006295299002245</els_id><sourcerecordid>70824440</sourcerecordid><originalsourceid>FETCH-LOGICAL-e292t-3c5155150417e975b8b9664db9b8f1944165e654ed83cea54bd56a7861a68c113</originalsourceid><addsrcrecordid>eNpFkdFuFCEUhonR2G31ETRcGKMXU2EGGPDGmKa2Jk16oV4TBs7sYmaGEZhN9jF8Y5nttiYkhHO-fHD4EXpDySUlVHz6QQgRVa14_UGpj4TUNav4M7Shsm1KWcjnaPOEnKHzlH6vRynoS3RGCaeNkmKD_t6G0U9bHHo8wdZkv4fhgO3OxC04bIZuKe2Ec8B5B3g4jPOuQBanQ8owfsY3MEE0A_bjPHhbWqHQfYjYxWWL86rJq78IZoh-3h3p7FNaIGEzObz3ayVCgrgPPqZX6EVvhgSvT_sF-vXt-ufVbXV3f_P96utdBbWqc9VYTnlZhNEWVMs72SkhmOtUJ3uqGKOCg-AMnGwsGM46x4Vpy_xGSEtpc4HeP3jnGP6Ux2Q9-mRhGMwEYUm6JbJmjJECvj2BSzeC03P0o4kH_fiJBXh3AkyyZuijmaxP_zlVbmUr9uUBgzLV3kPUyXqYLDgfwWbtgi9Ovaarj-nqNTqtlD6mq3nzD1vDmEY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70824440</pqid></control><display><type>article</type><title>Homing of negatively charged albumins to the lymphatic system: General implications for drug targeting to peripheral tissues and viral reservoirs</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Swart, Pieter J ; Beljaars, Leonie ; Kuipers, Mirjam E ; Smit, Catharina ; Nieuwenhuis, Paul ; Meijer, Dirk K.F</creator><creatorcontrib>Swart, Pieter J ; Beljaars, Leonie ; Kuipers, Mirjam E ; Smit, Catharina ; Nieuwenhuis, Paul ; Meijer, Dirk K.F</creatorcontrib><description>The present study shows the lymphatic distribution of the negatively charged anti-HIV-1 agents succinylated or aconytilated human serum albumins (HSAs) in rats. Quantitation of blood and lymphatic concentrations of these proteins was performed through fluorescence detection of the fluorescein isothiocyanate (FITC)-labeled proteins. At several time points after i.v. injection, samples were taken from the cannulated thoracic duct and the carotid artery. Distribution of the negatively charged albumins (NCAs) to lymph was much more rapid than that of albumin itself and was dependent on the total net negative charge added to the protein: the half-life times of lymphatic equilibration were 15, 30, and 120 min for FITC-labeled aconytilated HSA, FITC-labeled succinylated HSA, and FITC-labeled HSA, respectively. Lymph to blood concentration ratios of the studied compounds obtained at steady state approached unity. In addition, the fluorescence in both body fluids was shown to represent unchanged labeled proteins. It was therefore inferred that the NCAs efficiently passed the endothelial barrier from blood to the interstitial compartment. Subsequently, we studied whether a specialized process was involved in the endothelial passage of the NCAs to the lymph. The following observations supported such a mechanism: a) preinjection of the scavenger receptor blockers polyinosinic- and formaldehyde-treated HSA reduced the transport from blood to the lymphatic compartment of FITC-labeled aconytilated HSA by more than 90%; b) the rate of lymphatic distribution was largely reduced when the body temperature of the rat was lowered to 28°; and c) pre-administration of chloroquine resulted in a significant reduction in the lymphatic distribution of the NCAs. These data collectively indicate that a scavenger receptor-mediated process is involved in the transendothelial transport of NCAs. In situ localization in lymph nodes of the rat showed that FITC-labeled aconytilated and succinylated HSA are mainly present in the germinal center and parafollicular zones. The efficient distribution of these anionized proteins to the lymphatic system is of particular interest for HIV therapy, taking into account that replication of HIV mainly takes place in the lymphoid system. The observation that macromolecules, through charge modification, can extravasate through a receptor-mediated transcytotic process is potentially of major importance for the delivery of drugs with macromolecular carriers to cells not directly in contact with the blood.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/S0006-2952(99)00224-5</identifier><identifier>PMID: 10513986</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>AIDS/HIV ; Albumins - chemistry ; Albumins - pharmacokinetics ; Albumins - pharmacology ; Animals ; Anti-HIV Agents - chemistry ; Anti-HIV Agents - pharmacokinetics ; anti-HIV-1 therapy ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; Biological Transport ; Cells, Cultured ; diacytosis ; Drug Delivery Systems ; Electrochemistry ; endothelial transcytosis ; Fluorescein - metabolism ; HIV - drug effects ; Humans ; Lymphatic System - metabolism ; Lymphatic System - virology ; Male ; Medical sciences ; negatively charged albumins ; Pharmacology. Drug treatments ; polyanionic compounds ; Rats ; Rats, Wistar ; scavenger receptor ; Tissue Distribution</subject><ispartof>Biochemical pharmacology, 1999-11, Vol.58 (9), p.1425-1435</ispartof><rights>1999 Elsevier Science Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0006-2952(99)00224-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1978646$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10513986$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Swart, Pieter J</creatorcontrib><creatorcontrib>Beljaars, Leonie</creatorcontrib><creatorcontrib>Kuipers, Mirjam E</creatorcontrib><creatorcontrib>Smit, Catharina</creatorcontrib><creatorcontrib>Nieuwenhuis, Paul</creatorcontrib><creatorcontrib>Meijer, Dirk K.F</creatorcontrib><title>Homing of negatively charged albumins to the lymphatic system: General implications for drug targeting to peripheral tissues and viral reservoirs</title><title>Biochemical pharmacology</title><addtitle>Biochem Pharmacol</addtitle><description>The present study shows the lymphatic distribution of the negatively charged anti-HIV-1 agents succinylated or aconytilated human serum albumins (HSAs) in rats. Quantitation of blood and lymphatic concentrations of these proteins was performed through fluorescence detection of the fluorescein isothiocyanate (FITC)-labeled proteins. At several time points after i.v. injection, samples were taken from the cannulated thoracic duct and the carotid artery. Distribution of the negatively charged albumins (NCAs) to lymph was much more rapid than that of albumin itself and was dependent on the total net negative charge added to the protein: the half-life times of lymphatic equilibration were 15, 30, and 120 min for FITC-labeled aconytilated HSA, FITC-labeled succinylated HSA, and FITC-labeled HSA, respectively. Lymph to blood concentration ratios of the studied compounds obtained at steady state approached unity. In addition, the fluorescence in both body fluids was shown to represent unchanged labeled proteins. It was therefore inferred that the NCAs efficiently passed the endothelial barrier from blood to the interstitial compartment. Subsequently, we studied whether a specialized process was involved in the endothelial passage of the NCAs to the lymph. The following observations supported such a mechanism: a) preinjection of the scavenger receptor blockers polyinosinic- and formaldehyde-treated HSA reduced the transport from blood to the lymphatic compartment of FITC-labeled aconytilated HSA by more than 90%; b) the rate of lymphatic distribution was largely reduced when the body temperature of the rat was lowered to 28°; and c) pre-administration of chloroquine resulted in a significant reduction in the lymphatic distribution of the NCAs. These data collectively indicate that a scavenger receptor-mediated process is involved in the transendothelial transport of NCAs. In situ localization in lymph nodes of the rat showed that FITC-labeled aconytilated and succinylated HSA are mainly present in the germinal center and parafollicular zones. The efficient distribution of these anionized proteins to the lymphatic system is of particular interest for HIV therapy, taking into account that replication of HIV mainly takes place in the lymphoid system. The observation that macromolecules, through charge modification, can extravasate through a receptor-mediated transcytotic process is potentially of major importance for the delivery of drugs with macromolecular carriers to cells not directly in contact with the blood.</description><subject>AIDS/HIV</subject><subject>Albumins - chemistry</subject><subject>Albumins - pharmacokinetics</subject><subject>Albumins - pharmacology</subject><subject>Animals</subject><subject>Anti-HIV Agents - chemistry</subject><subject>Anti-HIV Agents - pharmacokinetics</subject><subject>anti-HIV-1 therapy</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>Biological Transport</subject><subject>Cells, Cultured</subject><subject>diacytosis</subject><subject>Drug Delivery Systems</subject><subject>Electrochemistry</subject><subject>endothelial transcytosis</subject><subject>Fluorescein - metabolism</subject><subject>HIV - drug effects</subject><subject>Humans</subject><subject>Lymphatic System - metabolism</subject><subject>Lymphatic System - virology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>negatively charged albumins</subject><subject>Pharmacology. Drug treatments</subject><subject>polyanionic compounds</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>scavenger receptor</subject><subject>Tissue Distribution</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkdFuFCEUhonR2G31ETRcGKMXU2EGGPDGmKa2Jk16oV4TBs7sYmaGEZhN9jF8Y5nttiYkhHO-fHD4EXpDySUlVHz6QQgRVa14_UGpj4TUNav4M7Shsm1KWcjnaPOEnKHzlH6vRynoS3RGCaeNkmKD_t6G0U9bHHo8wdZkv4fhgO3OxC04bIZuKe2Ec8B5B3g4jPOuQBanQ8owfsY3MEE0A_bjPHhbWqHQfYjYxWWL86rJq78IZoh-3h3p7FNaIGEzObz3ayVCgrgPPqZX6EVvhgSvT_sF-vXt-ufVbXV3f_P96utdBbWqc9VYTnlZhNEWVMs72SkhmOtUJ3uqGKOCg-AMnGwsGM46x4Vpy_xGSEtpc4HeP3jnGP6Ux2Q9-mRhGMwEYUm6JbJmjJECvj2BSzeC03P0o4kH_fiJBXh3AkyyZuijmaxP_zlVbmUr9uUBgzLV3kPUyXqYLDgfwWbtgi9Ovaarj-nqNTqtlD6mq3nzD1vDmEY</recordid><startdate>19991101</startdate><enddate>19991101</enddate><creator>Swart, Pieter J</creator><creator>Beljaars, Leonie</creator><creator>Kuipers, Mirjam E</creator><creator>Smit, Catharina</creator><creator>Nieuwenhuis, Paul</creator><creator>Meijer, Dirk K.F</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19991101</creationdate><title>Homing of negatively charged albumins to the lymphatic system: General implications for drug targeting to peripheral tissues and viral reservoirs</title><author>Swart, Pieter J ; Beljaars, Leonie ; Kuipers, Mirjam E ; Smit, Catharina ; Nieuwenhuis, Paul ; Meijer, Dirk K.F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e292t-3c5155150417e975b8b9664db9b8f1944165e654ed83cea54bd56a7861a68c113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>AIDS/HIV</topic><topic>Albumins - chemistry</topic><topic>Albumins - pharmacokinetics</topic><topic>Albumins - pharmacology</topic><topic>Animals</topic><topic>Anti-HIV Agents - chemistry</topic><topic>Anti-HIV Agents - pharmacokinetics</topic><topic>anti-HIV-1 therapy</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>Biological Transport</topic><topic>Cells, Cultured</topic><topic>diacytosis</topic><topic>Drug Delivery Systems</topic><topic>Electrochemistry</topic><topic>endothelial transcytosis</topic><topic>Fluorescein - metabolism</topic><topic>HIV - drug effects</topic><topic>Humans</topic><topic>Lymphatic System - metabolism</topic><topic>Lymphatic System - virology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>negatively charged albumins</topic><topic>Pharmacology. Drug treatments</topic><topic>polyanionic compounds</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>scavenger receptor</topic><topic>Tissue Distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swart, Pieter J</creatorcontrib><creatorcontrib>Beljaars, Leonie</creatorcontrib><creatorcontrib>Kuipers, Mirjam E</creatorcontrib><creatorcontrib>Smit, Catharina</creatorcontrib><creatorcontrib>Nieuwenhuis, Paul</creatorcontrib><creatorcontrib>Meijer, Dirk K.F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swart, Pieter J</au><au>Beljaars, Leonie</au><au>Kuipers, Mirjam E</au><au>Smit, Catharina</au><au>Nieuwenhuis, Paul</au><au>Meijer, Dirk K.F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homing of negatively charged albumins to the lymphatic system: General implications for drug targeting to peripheral tissues and viral reservoirs</atitle><jtitle>Biochemical pharmacology</jtitle><addtitle>Biochem Pharmacol</addtitle><date>1999-11-01</date><risdate>1999</risdate><volume>58</volume><issue>9</issue><spage>1425</spage><epage>1435</epage><pages>1425-1435</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>The present study shows the lymphatic distribution of the negatively charged anti-HIV-1 agents succinylated or aconytilated human serum albumins (HSAs) in rats. Quantitation of blood and lymphatic concentrations of these proteins was performed through fluorescence detection of the fluorescein isothiocyanate (FITC)-labeled proteins. At several time points after i.v. injection, samples were taken from the cannulated thoracic duct and the carotid artery. Distribution of the negatively charged albumins (NCAs) to lymph was much more rapid than that of albumin itself and was dependent on the total net negative charge added to the protein: the half-life times of lymphatic equilibration were 15, 30, and 120 min for FITC-labeled aconytilated HSA, FITC-labeled succinylated HSA, and FITC-labeled HSA, respectively. Lymph to blood concentration ratios of the studied compounds obtained at steady state approached unity. In addition, the fluorescence in both body fluids was shown to represent unchanged labeled proteins. It was therefore inferred that the NCAs efficiently passed the endothelial barrier from blood to the interstitial compartment. Subsequently, we studied whether a specialized process was involved in the endothelial passage of the NCAs to the lymph. The following observations supported such a mechanism: a) preinjection of the scavenger receptor blockers polyinosinic- and formaldehyde-treated HSA reduced the transport from blood to the lymphatic compartment of FITC-labeled aconytilated HSA by more than 90%; b) the rate of lymphatic distribution was largely reduced when the body temperature of the rat was lowered to 28°; and c) pre-administration of chloroquine resulted in a significant reduction in the lymphatic distribution of the NCAs. These data collectively indicate that a scavenger receptor-mediated process is involved in the transendothelial transport of NCAs. In situ localization in lymph nodes of the rat showed that FITC-labeled aconytilated and succinylated HSA are mainly present in the germinal center and parafollicular zones. The efficient distribution of these anionized proteins to the lymphatic system is of particular interest for HIV therapy, taking into account that replication of HIV mainly takes place in the lymphoid system. The observation that macromolecules, through charge modification, can extravasate through a receptor-mediated transcytotic process is potentially of major importance for the delivery of drugs with macromolecular carriers to cells not directly in contact with the blood.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10513986</pmid><doi>10.1016/S0006-2952(99)00224-5</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2952
ispartof Biochemical pharmacology, 1999-11, Vol.58 (9), p.1425-1435
issn 0006-2952
1873-2968
language eng
recordid cdi_proquest_miscellaneous_70824440
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects AIDS/HIV
Albumins - chemistry
Albumins - pharmacokinetics
Albumins - pharmacology
Animals
Anti-HIV Agents - chemistry
Anti-HIV Agents - pharmacokinetics
anti-HIV-1 therapy
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Biological and medical sciences
Biological Transport
Cells, Cultured
diacytosis
Drug Delivery Systems
Electrochemistry
endothelial transcytosis
Fluorescein - metabolism
HIV - drug effects
Humans
Lymphatic System - metabolism
Lymphatic System - virology
Male
Medical sciences
negatively charged albumins
Pharmacology. Drug treatments
polyanionic compounds
Rats
Rats, Wistar
scavenger receptor
Tissue Distribution
title Homing of negatively charged albumins to the lymphatic system: General implications for drug targeting to peripheral tissues and viral reservoirs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T13%3A43%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homing%20of%20negatively%20charged%20albumins%20to%20the%20lymphatic%20system:%20General%20implications%20for%20drug%20targeting%20to%20peripheral%20tissues%20and%20viral%20reservoirs&rft.jtitle=Biochemical%20pharmacology&rft.au=Swart,%20Pieter%20J&rft.date=1999-11-01&rft.volume=58&rft.issue=9&rft.spage=1425&rft.epage=1435&rft.pages=1425-1435&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/S0006-2952(99)00224-5&rft_dat=%3Cproquest_pubme%3E70824440%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70824440&rft_id=info:pmid/10513986&rft_els_id=S0006295299002245&rfr_iscdi=true